Picture of Vericel logo

VCEL — Vericel News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Vericel Corp reports results for the quarter ended in December - Earnings Summary

* Vericel Corp  VCEL.OQ  reported quarterly adjusted
earnings of
12 cents​​ per share for the quarter ended in December. The mean
expectation of five analysts for the quarter was for earnings of
4 cents per share.
    * Revenue rose 10.7% to $52.69 million from a year ago;
analysts
expected $52.94 million. 
    * Vericel Corp's reported EPS for the quarter was 12 cents​.
    * The mean earnings estimate of analysts had fallen by
about 2.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Vericel Corp shares had risen by 8.3% this quarter.
    * The company reported quarterly net income of $5.92
million.
    * Wall Street's median 12-month price target for Vericel
Corp is
$36.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
23 at 02:33 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      0.04           0.12           Beat
 Sep. 30 2022      -0.10          -0.14          Missed
 Jun. 30 2022      -0.12          -0.19          Missed
 Mar. 31 2022      -0.12          -0.15          Missed

Recent news on Vericel

See all news